• B-Cell Lymphoma, FISH, Blood
  • Platelet Function Analysis
  • Cystic fibrosis
  • von Willebrand Disease 2N (Subtype Normandy), Genotyping
  • Ki-67
  • Malignant neoplasm, uterine cervix (cervical cancer)
  • Insulin-Like Growth Factor I (IGF1)
  • Gastric Parietal Cell Antibody, IgG
  • CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Blood
  • Brucella Nucleic Acid Detection by PCR
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Specimen Collection
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.